These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Practical therapeutics--use of oral anti-diabetic agents. Obel AO East Afr Med J; 1982 Feb; 59(2):91-5. PubMed ID: 7128503 [No Abstract] [Full Text] [Related]
27. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents]. Pernet A; Bäbler M; Ganz K Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361 [No Abstract] [Full Text] [Related]
28. How long are oral antidiabetic drugs effective? Breidahl HD Aust Fam Physician; 1976 May; 5(4):445-51. PubMed ID: 952629 [No Abstract] [Full Text] [Related]
29. [Effects of some oral hypoglycemia drugs on blood levels of lactic and pyruvic acid in diabetes mellitus]. Sgambato S; Bisesti V; Giugliano D; Passariello N; Saccomanno F Clin Ter; 1980 Apr; 93(2):183-92. PubMed ID: 7449337 [No Abstract] [Full Text] [Related]
30. [Sulfonylurea compounds or biguanides in the treatment of type 2 diabetes?]. Mehnert H Dtsch Med Wochenschr; 1989 Jul; 114(27):1086-8. PubMed ID: 2500320 [No Abstract] [Full Text] [Related]
31. Editorial: Oral therapy in diabetes mellitus. Scoville AB South Med J; 1974 Jun; 67(6):635-8. PubMed ID: 4208385 [No Abstract] [Full Text] [Related]
32. The oral hypoglycaemic agents reassess. Drug Ther Bull; 1974 Mar; 12(5):17-20. PubMed ID: 4820614 [No Abstract] [Full Text] [Related]
33. [New aspects of therapy with oral antidiabetic agents]. Haslbeck M Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940 [No Abstract] [Full Text] [Related]
34. [Biguanides in the treatment of obesity]. Giulietti M Clin Ter; 1978 Jan; 84(1):99-100. PubMed ID: 415837 [No Abstract] [Full Text] [Related]
36. The rationale for the use of drugs in the treatment of diabetes mellitus. Kryston LJ; Shaw RA Semin Drug Treat; 1974; 3(4):365-75. PubMed ID: 4207077 [No Abstract] [Full Text] [Related]
37. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide]. Birk W; Petrides P Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033 [No Abstract] [Full Text] [Related]
38. [Thyroid function in diabetics treated with sulfonylurea and biguanides]. Kasperska-Czyzykowa T; Czech W; Sawicki Z; Woy-Wojciechowski J; Zuławnik W Pol Arch Med Wewn; 1978 Mar; 59(3):275-83. PubMed ID: 580962 [No Abstract] [Full Text] [Related]
39. [Is there still room for the biguanides?]. Doorenbos H Ned Tijdschr Geneeskd; 1977 Dec; 121(49):1961-3. PubMed ID: 927574 [No Abstract] [Full Text] [Related]
40. Oral hypoglycemic agents: the pharmacological basis of their clinical use. Davidoff F R I Med J; 1973 Oct; 56(10):409-14. PubMed ID: 4518221 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]